Skip to main content

Table 2 Effects of melatonin on fasting plasma glucose, serum transaminase, and lipid levels

From: Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice

 

Group A

Group B

Group C

Group D

FPG, mmol/L

5.03 ± 0.38*

8.45 ± 0.35#

4.71 ± 0.29

4.85 ± 0.33

HDL, mmol/L

1.71 ± 0.53

1.51 ± 0.39

2.05 ± 0.43

1.99 ± 0.37

LDL, mmol/L

0.24 ± 0.06*

1.57 ± 0.10#

0.28 ± 0.06

0.29 ± 0.03

TG, mmol/L

1.11 ± 0.35

1.06 ± 0.24

1.18 ± 0.15

1.24 ± 0.18

AST, IU/L

20.31 ± 4.41

20.01 ± 1.20

14.98 ± 4.39

13.35 ± 1.57

ALT, IU/L

24.33 ± 11.90*

60.80 ± 10.18#

13.01 ± 3.49

16.62 ± 2.00

  1. Group A: HFD + MLT, Group B: HFD, Group C: RD + MLT, Group D: RD. FPG fasting plasma glucose, HDL high-density cholesterol, LDL low-density cholesterol, TG Triglycerides, AST aspartate aminotransferase and ALT Alanine aminotransferase. *P < 0.05 for group A vs group B; #P < 0.05 for group B vs group D
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X